-
FDA approves Epson Bio to expand Dysport injection spree
Time of Update: 2020-06-08
recently, the , epson bio pharmaceutical (http:// company (http:// announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved the expansion of the scope of D
-
Phase 3 clinical trial of Diroximel fumarate for treatment of RRMS yields positive top-line results
Time of Update: 2020-06-08
recently, the (http:// of the company of Alkermes and Biogen announced positive top-line results a Phase 3 clinical trial (http:// for the treatment of recurrent recurrent multiple sclerosis (R
-
Yan Noi's new antibiotic cefiderocol treatment hospital obtained pneumonia adult patients 3 study reached the main endpoint
Time of Update: 2020-06-08
recently, Japan's Shionogi company (http:// announced that it had developed a new antibiotic, cefiderocol, to reach the main endpoint of the experimental (http:// in the phase 3 study of APEKS
-
FDA grants Merck MET inhibitor tepotinib breakthrough therapy designation
Time of Update: 2020-06-08
Today, Merck KGaA announced that the U.S FDA (http:// granted its MET inhibitor tepotinib breakthrough therapy to treat mettostatic non-small cell lung cancer (NSCLC) patients with MET exmetro 14
-
China's State Drug Administration approves Gilead compound preparation bitovi® (Biken pronosis) for the treatment of HIV-1 virus infection
Time of Update: 2020-06-08
Recently, Gilead Sciences (NASDAQ: GILD) announced that its daily service mono-combination formulation, the Pitutovi ® (Biken pronotablets), has been approved by China's National Medicines (http:/
-
FDA approves pretomanid to treat tuberculosis patients in combination with bedaquiline and linezolid
Time of Update: 2020-06-08
Today, the U.S FDA (http:// announced the approval of pretomanid, developed by the non-profit global TB drug (http:// Development Alliance (TB Alliance), to treat specific highly drug-resistan
-
FDA grants Achillion's danicopan breakthrough therapy
Time of Update: 2020-06-08
a sleeping hemoglobinuria (PNH) is a acquired, life-threatening rare blood disease characterized by the destruction of red blood cells (hemolytic anemia), blood clots (thrombosis), impaired bone mar
-
U.S. Antimicrobial Advisory Board backs Gilead Descovy to reduce risk of HIV infection
Time of Update: 2020-06-08
AIDS is an infectious disease caused by HIV infection The development of modern antiviral drug (http:// and the rise of "cocktail therapy" has allowed HIV-infected people to control their conditi
-
CHMP approves Epidyolex for treatment of epilepsy associated with LGS and DS and older
Time of Update: 2020-06-08
recently, the (http:// ) of GW Pharma announced in the UK that the European Medicines (http:// Authority ( HTTP://WWW.CHEMDRUG.COM/) product sems (http:// Committee recommended approval of
-
FDA approves Bavarian's Jynneos vaccine to be marketed to prevent smallpox and monkeypox infections
Time of Update: 2020-06-08
today (September 25), 's FDA (http:// ) approved the company's Jynneos vaccine to prevent smallpox and monkeypox infections among high-risk adults over the age of 18, the 's and the fda's anno
-
AstraZeneca AZD1775 positive results in clinical trial synod with chemotherapy and radiotherapy in combination with localized advanced pancreatic cancer
Time of Update: 2020-06-08
pancreatic cancer is one of the most deadly cancers and is also known as the "King of Cancer" In 2018, about 55,000 people in the United States will be diagnosed with pancreatic cancer, and more tha
-
Gilead submitted a new drug application for JAK1 inhibitor filgotinib to MHLW
Time of Update: 2020-06-08
recently, Gilead Sciences announced that the company (http:// has submitted to The Ministry of Health, Labour and Welfare (MHLW) an application for new drug (http:// (NDA) of the oral selectiv
-
FDA approves Ardelyx public bsrela (tenapanor) for treatment of IBS-C adult patients
Time of Update: 2020-06-08
The U.S fda (http:// approved the listing of the company's Ibsrela (tenapanor) to treat adult patients with constipation-type irritable bowel syndrome (IBS-C), (http:// announced About Ibsrel
-
FDA grants Corchi bio-whole BCMA CAR-T cell (CT053) "orphan drug" qualification
Time of Update: 2020-06-08
recently, cozie bio pharmaceutical (http:// (Shanghai) limited company (http:// (CARsgen Therapeutics) announced that the U.S Food medicine s (http:// Regulatory Authority (US FDA (http://
-
Roche Tecentriq clinical study for stage III of urinary skin cancer reaches major endpoint
Time of Update: 2020-06-08
Recently, Roche, the Swiss Pharmaceutical (http:// giant, announced that IMvigor130, a phase III clinical study on the treatment of urinary skin cancer (UC) on the first line of the PD-L1 tumor i
-
Colum Pharmaceuticals' innovative tumor immunotherapy drug KL-A293 injections receive disservice to the National Drug Administration
Time of Update: 2020-06-08
Today, Colum Pharmaceuticals announced that its holding son company (http:// Columbotai and Anyuan Pharmaceutical (http:// to obtain the notice of the National Drug (http:// Clinical Tri
-
FDA accepts new drug application for Sumitomo Pharmaceuticals dasotraline to treat BED
Time of Update: 2020-06-08
recently, Sumitomo Pharmaceutical (http:// u.S sub- company (http:// Sunovion Pharma announced that the U.S Food and Medicines (http:// Administration ( FDA (http:// ) has accepted the tre
-
Jazz's JZP-258 reaches primary and secondary endpoints in Phase 3 trial to treat excessive drowsiness in the day
Time of Update: 2020-06-08
Today, Jazz Pharmaceuticals (http:// announced that it has reached its primary and critical secondary endpoints in the of the phase 3 trial (http:// treating adult adult psychotic sleepiness
-
Ultragenyx submits NEW drug application to UX007 (triheptanoin) to FDA
Time of Update: 2020-06-08
LC-FAOD is a group of autosomal recessive genetic diseases characterized by metabolic defects in the body's inability to convert long-chain fatty acids into energy Failure to generate energy from fa
-
Cinda Bio publishes the results of phase 3 double-blind phase 3 of IBI305 treatment for advanced non-squamous non-small cell lung cancer
Time of Update: 2020-06-08
recently, cinda Bio Pharmaceutical s (http:// (http:// announced the results of the study of the effectiveness and safety of IBI305 (bevalbea mono-antibiotic) and beva-beth-single anti-co-purp
